Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T29633 |
AD 5
AD-5,AD5 |
||
AD 5 is a bioactive chemical. | |||
T1180 |
Blonanserin
布南色林,AD-5423 |
Dopamine Receptor; Sigma receptor; 5-HT Receptor; Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Blonanserin (AD-5423) 是一种有效的5-HT2A 和多巴胺 D2 受体拮抗剂,Ki 为 0.812 和 0.142 nM,是一种非典型的抗精神病试剂。 | |||
T10558 |
Blonanserin D5
AD-5423 D5 |
Others | Others |
Blonanserin D5 is a deuterium-labeled Blonanserin. Blonanserin (AD-5423) is a dopamine D2/5-HT2 receptor antagonist with an atypical antipsychotic effect. | |||
T10559 |
Blonanserin D8
AD-5423 D8 |
Others | Others |
Blonanserin D8 is a deuterium-labeled Blonanserin. Blonanserin (AD-5423) is a dopamine D2/5-HT2 receptor antagonist with an atypical antipsychotic effect. | |||
T79684 |
5-HT6R antagonist 1
|
5-HT Receptor | GPCR/G Protein; Neuroscience |
5-HT6R antagonist 1(Compound 8)是一款具有突出代谢稳定性的5-HT6R拮抗剂(Ki: 5 nM),能有效抑制血小板聚集,并可逆转由MK-801引起的大鼠记忆障碍。此化合物在阿尔茨海默病(AD)的研究中有潜在应用价值。 | |||
T27269 |
Ensaculin HCl
KA 672,KA672,Ensaculin,Anseculin Hydrochloride,KA-672 HCl |
||
Ensaculin is a NMDA antagonist and a 5HT1A agonist potentially for the treatment of Alzheimer's disease (AD). Ensaculin showed memory-enhancing effects in paradigms of passive and conditioned avoidance in both normal and artificially amnesic rodents. It e | |||
T72893 | AChE/MAO-IN-2 | ||
Dual AChE-MAO B-IN-5 是一种茚满酮衍生物,是一种有效的双重 AChE/MAO-B 抑制剂,对 AChE、MAO-B 和 MAO-A 的IC50值分别为 0.0224、0.0412 和 0.1116 μM。Dual AChE-MAO B-IN-5 具有抗氧化活性,防止 β-淀粉样斑块聚集。Dual AChE-MAO B-IN-5 可用于阿尔茨海默病 (AD) 研究。 | |||
T79533 |
PDE5-IN-10
|
||
PDE5-IN-10 (compound 4b),一有效PDE5抑制剂,IC50值为20 nM。该化合物体外微粒体稳定性增强(t1/2= 44.6 分钟),在长期增强恢复方面效果显著,适用于阿尔茨海默病(AD)研究。 | |||
T63216 |
γ-Secretase modulator 11
|
||
5-{8-[(3,4'-二氟[1,1'-联苯]-4-基)甲氧基]-2-甲基咪唑并[1,2-a]吡啶-3-基}-N-甲基吡啶-2-甲酰胺(1o)具有较高的体外效力和脑暴露效果,能够使脑Aβ42水平的明显降低,且对细胞色素p450酶无抑制作用。此外,化合物1o 在AD 模型小鼠中表现出优异的抗认知缺陷作用。 | |||
T74461 | Chalcones A-N-5 | ||
ChalconesA-N-5, 一种三羟基查耳酮衍生物化合物,浓度低于100 µM (IC50> 1 mM) 时无细胞毒性,能显着促进细胞增殖。此外,ChalconesA-N-5 能促进受损脑组织中神经元的生长,抑制RSL或erastin诱导的铁死亡,并降低Aβ1-42蛋白聚集引发的脂质过氧化水平。因此,ChalconesA-N-5 作为分子骨架的候选物,对于开发用以研究AD的体内试验先导化合物具有重要潜力。 | |||
T38002 | LEO 39652 | ||
LEO 39652 is a dual-soft PDE4 inhibitor with IC50s of 1.2 nM, 1.2 nM, 3.0 nM and 3.8 nM for PDE4A, PDE4B, PDE4C and PDE4D, respectively. LEO 39652 also inhibits TNF-α with an IC50 value of 6.0 nM. LEO 39652 is used for topical research of Atopic dermatitis (AD) [1]. LEO 39652 shows unbound in vitro potency when measured as LPS induced TNF-α release in human peripheral blood mononuclear cells (PBMC), incubated in serum free medium. LEO 39652 shows a relatively high binding to human serum albumin... | |||
T37847 |
Zonisamide-13C2,15N
Zonisamide-13C2,15N |
||
Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml.2 In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium... |